Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis.

ABSTRACT:

Background

Corona virus disease 2019 (COVID-19) has spread around the world since its outbreak, and there is no ascertained effective drug up to now. Lianhua Qingwen (LHQW) has been widely used in China and overseas Chinese, which had some advantages in the treatment of COVID-19.

Objective

To evaluate the efficacy and safety of LHQW for COVID-19 by conducting a systematic review with meta-analysis.

Methods

A comprehensive literature search was conducted in 12 electronic databases from their establishment to October 30, 2021. Note Express 3.2.0 was used for screening of trials, and the data was independently extracted in duplicate by 2 researchers. The risk of bias of randomized controlled trials (RCTs) and retrospective studies were assessed by using the Cochrane coll

SUBMITTER: Sun XH 

PROVIDER: S-EPMC9247911 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature